NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-105-2012-0-CH-30 Medical Use of Cells Comprising Anti-NY-ESO-1 T Cell Receptors CH EP 19152955.1 Issued
NCI E-105-2012-0-GB-34 Murine Anti-NY-ESO-1 T Cell Receptors GB EP 19152955.1 Issued
NCI E-105-2012-0-ES-32 Murine Anti-NY-ESO-1 T Cell Receptors ES EP 19152955.1 Issued
NCI E-105-2012-0-PT-38 Murine Anti-NY-ESO-1 T Cell Receptors PT EP 19152955.1 Issued
NCI E-105-2012-0-NL-37 Murine Anti-NY-ESO-1 T Cell Receptors NL EP 19152955.1 Issued
NCI E-105-2012-0-EP-15 Murine Anti-NY-ESO-1 T Cell Receptors EP DIV 19152955.1 Issued
NCI E-105-2012-0-BE-29 Murine Anti-NY-ESO-1 T Cell Receptors BE EP 19152955.1 Issued
NCI E-105-2012-0-DE-31 Murine Anti-NY-ESO-1 T Cell Receptors DE EP 19152955.1 Issued
NCI E-105-2012-0-FR-33 Murine Anti-NY-ESO-1 T Cell Receptors FR EP 19152955.1 Issued
NEI E-284-2012-2-PCT-08 METHODS AND COMPOSITIONS FOR TREATING GENETICALLY LINKED DISEASES OF THE EYE PCT PCT PCT/US2019/014418 Expired
NIAID E-146-2004-0-US-05 Monoclonal Antibodies that Neutralize Anthrax Protective Antigen (PA) Toxin US DIV 16/253,077 Abandoned
NCI E-094-2017-2-US-03 Fully Human Antibody Binders To Human Mesothelin For CAR-T Therapeutics Treatment US CON 16/252,158 10550179 Issued PDF
NIAID E-033-2018-0-PCT-02 Development Of A Broadly Protective Influenza Vaccine Consisting Of A Cocktail Of Inactivated Avian Influenza Viruses 1 PCT PCT PCT/US2019/014220 Expired
NCI E-236-2017-0-PCT-02 Anti-cancer Activity Of SCGB3A2 PCT PCT PCT/US2019/014189 Expired
NIAID E-033-2018-0-CN-03 BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE CN National Stage 201980009484.7 Pending
NIAID E-033-2018-0-EP-04 BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE EP National Stage 19717381.8 Pending
NIAID E-033-2018-0-IN-05 Development Of A Broadly Protective Influenza Vaccine Consisting Of A Cocktail Of Inactivated Avian Influenza Viruses 1 IN National Stage 202017031357 Pending
NCI E-031-2014-0-US-05 COMPOSITIONS COMPRISING PCSK9 PEPTIDE CONJUGATED TO A QBETA CARRIER AND METHODS OF USING THE SAME US CON 16/250,514 10925938 Issued PDF
NIA E-214-2018-0-PCT-02 PHENOTYPIC AGE AND DNA METHYLATION BASED BIOMARKERS FOR LIFE EXPECTANCY AND MORBIDITY PCT PCT PCT/US2019/014053 Expired
NIA E-214-2018-0-EP-03 PHENOTYPIC AGE AND DNA METHYLATION BASED BIOMARKERS FOR LIFE EXPECTANCY AND MORBIDITY EP National Stage 19741202.6 Pending
NEI E-134-2016-0-AU-03 Selective Estrogen-receptor Modulators (SERMs) Confer Protection Against Photoreceptor Degeneration AU National Stage 2017312499 Issued
NIAID E-099-2016-0-US-16 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US CON 16/249,721 10682379 Issued PDF
NIAID E-099-2016-0-US-15 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US CON 16/244,903 Abandoned
NHGRI E-031-2018-0-PCT-02 DETECTING PROTEIN INTERACTION SITES IN NUCLEIC ACIDS PCT PCT PCT/US2019/012851 Expired
NCI E-265-2015-0-HK-15 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS HK EP 19100263.9 Issued
NIAID E-135-2010-0-GR-28 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production GR EP 19150800.1 Issued
NIAID E-135-2010-0-IE-29 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production IE EP 19150800.1 Issued
NIAID E-135-2010-0-IT-30 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production IT EP 19150800.1 Issued
NIAID E-135-2010-0-BE-19 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production BE EP 19150800.1 Issued
NIAID E-135-2010-0-AT-18 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production AT EP 19150800.1 Issued
NIAID E-135-2010-0-TR-35 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production TR EP 19150800.1 Issued
NIAID E-135-2010-0-CH-20 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production CH EP 19150800.1 Issued
NIAID E-135-2010-0-GB-27 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production GB EP 19150800.1 Issued
NIAID E-135-2010-0-EP-07 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production EP DIV 19150800.1 Issued
NIAID E-135-2010-0-NO-36 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production NO EP 19150800.1 Issued
NIAID E-135-2010-0-SE-34 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production SE EP 19150800.1 Issued
NIAID E-135-2010-0-PT-33 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production PT EP 19150800.1 Issued
NIAID E-135-2010-0-ES-24 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production ES EP 19150800.1 Issued
NIAID E-135-2010-0-PL-32 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production PL EP 19150800.1 Issued
NIAID E-135-2010-0-DK-23 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production DK EP 19150800.1 Issued
NIAID E-135-2010-0-CZ-21 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production CZ EP 19150800.1 Issued
NIAID E-135-2010-0-FR-26 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production FR EP 19150800.1 Issued
NIAID E-135-2010-0-DE-22 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production DE EP 19150800.1 Issued
NIAID E-135-2010-0-FI-25 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production FI EP 19150800.1 Issued
NIAID E-135-2010-0-NL-31 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production NL EP 19150800.1 Issued
NHLBI E-122-2006-0-US-06 The Discovery Of A Previously Uncharacterized Gene Whose Expression Is Restricted To Renal Cell Carcinoma (RCC) Cells US CON 16/241,017 10557118 Issued PDF
NCATS E-021-2016-0-US-16 Antifungal Compound Process US DIV 16/241,036 10392365 Issued PDF
NIDA E-280-2015-0-US-02 Auto Rim-Shaped Gradient Coil US ORD 16/239,747 10739427 Issued PDF
NIAID E-158-2007-3-US-06 Live Attenuated Virus Vaccines for La Crosse Virus and other Bunyaviridae US DIV 16/240,222 10561724 Abandoned PDF
NIAID E-154-2017-0-PCT-02 NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE PCT PCT PCT/US2018/068198 Expired